The PMS, Perinatal, & Postpartum
Research Program

An Online Guide to the latest research in Women's Health


PMS/PMDD: Getting Treatment

 

Do you get tense, irritable, angry, sad or moody the week before your period?

If you do, you could qualify for a research study.

Women between the ages of 18 and 48 are currently being screened for  participation in a research study offered by the Yale University School of    Medicine for the treatment of Premenstrual Dysphoric Disorder or severe         PMS symptoms.

Qualified participants will receive study medication, and compensation up to $325.

                                  

We take PMS seriously!

Yale University School of Medicine • An equal opportunity institution

HIC Number: 0609001839

New Haven 203-764-5719

Toll Free: 1-866-600-MOOD

 

 

We currently have 2 active studies...

 

Sertraline (also known as Zoloft) to treat moderate PMS.  Sertraline (FDA approved as Zoloft for the treatment of PMDD) is being investigated in a "symptom-onset" dosing format in our newest study.  This study doses the active medication or placebo for the symptomatic days before you get your period to treat moderate emotional symptoms of PMS.  Women appreciate the benefit of medication while not needing to take pills all month long.  Another easy treatment study which offers high quality free care and flexible scheduling, with up to $325 reimbursement.  More details at www.sospmdd.com  

Call (203)764-5719 or  Email Joanne for info 

 

Calcium vs. fluoxetine (also known as Prozac or Sarafem), compared to placebo, to treat mild-moderate PMS symptoms.  This study evaluates which is more effective to treat emotional and physical premenstrual discomforts- medication or calcium?  The study is 7 months long and offers free treatment, although no compensation.  The visit schedule is very easy on your time and schedule- office visits are flexible and many appointments are over the telephone.  Se habla espaņol. 

Call (203)764-5719 or  Email Joanne for info

 

Antidepressant Medication used in research trials:

Fluoxetine (FDA approved as Sarafem for the treatment of PMDD) is compared to calcium in a clinical trial to treat premenstrual symptoms.  Sertraline (FDA approved as Zoloft for the treatment of PMDD) is being investigated in a "symptom-onset" dosing format in our new study which opened to enrollment in 2007. 

Dr. Yonkers and a host of other women's health researchers have discovered that levels of the neurochemical serotonin, which plays a role in depression and anxiety, differ in women who suffer from PMS or PMDD.  Drugs that regulate levels of serotonin, such as fluoxetine, sertraline and paroxetine, are known to be effective treatments for the mood symptoms of PMS.  Calcium may be effective for the physical symptoms of PMS.  The PMS & Postpartum Research Center is currently investigating this with funds provided by the Donaghue Women's Health Foundation.

  "Each study is different," Dr. Yonkers explains, "because we treat moderate to severe mood, behavioral, and physical symptoms with different medications.  We have options for just about everyone with PMS or PMDD.  There is help for women suffering from premenstrual symptoms."

Basic study participant qualifications:

The First Step:

 


 

The PMS, Perinatal, & Postpartum Research Program
142 Temple Street, Suite 301
New Haven, CT 06510
Phone: (203) 764-6621
Toll-Free: (866) 600-6663
Fax: (203) 764-6766

women@yale.edu